Dr. Young is interested in providing excellent care to adults with kidney disease. This includes those with reduced kidney function, electrolyte imbalance, hypertension, as well as patients requiring long-term kidney replacement therapy such as dialysis.
M.D., UC Los Angeles / Drew School of Medicine, Los Angeles CA 2002
B.A., Harvard University, Cambridge MA 1998
Internal Medicine, UC Los Angeles School of Medicine, Los Angeles CA 2002-2005
Nephrology, UC Los Angeles School of Medicine, Los Angeles CA 2005-2007
American Board of Internal Medicine,
American Board of Internal Medicine, Nephrology,
Alpha Omega Alpha
American Society of Nephrology
National Kidney Foundation
Honors and Awards
Stanford Nephrology Division Teaching Attending of the Year 2012, 2014, 2015
UCLA Outstanding Problem Based Learning Small Group Tutor, 2009
UCLA Internal Medicine Residency Program Teaching Fellow of the Year, 2007
Charles R. Drew School of Medicine Gold Medal, 2002
Select Recent Publications
Reduction of serum hepcidin by hemodialysis in pediatric and adult patients. Zaritsky J, Young B, Gales B, Wang HJ, Rastogi A, Westerman M, Nemeth E, Ganz T, Salusky IB. Clin J Am Soc Nephrol. 2010 Jun;5(6):1010-4.
Hepcidin for clinicians. Young B, Zaritsky J. Clin J Am Soc Nephrol. 2009 Aug;4(8):1384-7.
Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, Ganz T, Rivera S, Nissenson AR, Salusky IB. Clin J Am Soc Nephrol. 2009 Jun;4(6):1051-6.
Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics: an analysis of the OPTN/UNOS database. Young BY, Gill J, Huang E, Takemoto SK, Anastasi B, Shah T, Bunnapradist S. Clin J Am Soc Nephrol. 2009 Apr;4(4):845-52.